Foresight Diagnostics Expands Scientific Advisory Board with Appointment of Christopher R. Flowers, M.D., M.S.
Apr 27, 2022 Foresight Diagnostics today announced the appointment of Christopher R. Flowers, M.D., M.S., to its Scientific Advisory Board (SAB). Dr. Flowers is an oncologist specializing in the treatment of B cell lymphoma and rare subtypes of lymphoma. He currently serves as Chair and Professor in the Department of Lymphoma-Myeloma in the Division of Cancer […]